| abstract |
(57) [Summary] The following formula I: Where A is a straight or branched C 1-6 -alkyl, alkoxy-alkyl, or alkenyl; X is O or NH; Y is O, S, NH, NCN, or N—C 1 -6 -alkyl; R 1 is 6-fluoro-1,2-benzisoxazol-3-yl, 6-fluoro-1H-indazol-3-yl, or 6-fluoro-1-methyl-1H-indazole. -3-yl; R 2 is alkyl or phenyl: and R 3 is optionally substituted phenyl, or R 3 is of the formula: (Wherein Z represents a 5- or 6-membered heterocyclic ring); or R 2 and R 3 together with the nitrogen atom form a condensed heterocyclic ring) The pharmaceutically acceptable salts are useful in treating conditions related to the CNS-system, cardiovascular system or gastrointestinal disorders. |